510(k) · Cleared
ClearedXPress BCD Breast Compression Device
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Xpress Bcd, LLC · POY Post Breast Biopsy Hemostatic Breast Compression Device
Cleared on Jul 19, 2017 as substantially equivalent to K113607 (Giotto USA, LLC, 2012) after a 229-day review. Its family tree reaches back 4 generations to 1992.
- Decided
- Jul 19, 2017
- Review
- 229 days
- Class
- Class II
- Product code
- POY
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 4 generations to K923061 (1992). No later device cites it as a predicate yet.
- Root · 4 generations backK923061 MammoscanFischer Imaging Corp. · 1992
- 3 generations backK990192 Biopsy-DigitSitco, Inc. · 1999
- 2 generations backK062039 Biopsy Digit-AMGiotto USA, LLC · 2006
- 1 generation backK113607 Biopsy Digit S Biopsy SLGiotto USA, LLC · 2012
- This deviceK163388 XPress BCD Breast Compression DeviceXpress Bcd, LLC · 2017
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K923061 | Mammoscan | Fischer Imaging Corp. | 1992 | — |
| −3 | K990192 | Biopsy-Digit | Sitco, Inc. | 1999 | — |
| −2 | K062039 | Biopsy Digit-AM | Giotto USA, LLC | 2006 | — |
| −1 | K113607 | Biopsy Digit S Biopsy SL | Giotto USA, LLC | 2012 | — |
| 0 (this device) | K163388 | XPress BCD Breast Compression Device | Xpress Bcd, LLC | 2017 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in POY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K113607 | Biopsy Digit S Biopsy SLSummary page 4…de: POY Regulation Number: 892.1710 Classification Panel: Radiology 4.0 PREDICATE DEVICE Device Trade Name: Biopsy Digit S and Biopsy Digit SL 510(k) Control Number: K113607 Product Code: IZH Manufacturer: Giotto USA, LLC, Wichita, KS 5.0 INDICATIONS FOR USE The Xpress BCD is a reusable device indi… | 2012 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 25 years and passes through 4 companies; a new generation was cleared every 6.5 years on median.
- None of the 4 ancestors has a recall.
How does its category compare?
All POY devicesPOY Post Breast Biopsy Hemostatic Breast Compression Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · POY
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · POY
Too few POY 510(k)s in any year since 2007 to give a median.
Recalls per year · POY
No recall names POY since 2007.
Adverse event reports per year · POY
1in 2018
MAUDE reports naming product code POY, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Xpress BCD is a reusable device indicated for use with stereotactic biopsy platforms to apply temporary focal mechanical compression to a stereotactic breast biopsy site to achieve hemostasis.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K163388 · printed Nov 6, 2026
Cite this page
510(k) Report. “K163388: XPress BCD Breast Compression Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K163388
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026